| 1 |
Schissel CK, Farquhar CE, Loas A, Malmberg AB, Pentelute BL. In-Cell Penetration Selection-Mass Spectrometry Produces Noncanonical Peptides for Antisense Delivery. ACS Chem Biol 2023;18:615-28. [PMID: 36857503 DOI: 10.1021/acschembio.2c00920] [Reference Citation Analysis]
|
| 2 |
Jackson MA, Xie J, Nguyen LTT, Wang X, Yap K, Harvey PJ, Gilding EK, Craik DJ. Plant-based production of an orally active cyclotide for the treatment of multiple sclerosis. Transgenic Res 2023. [PMID: 36930229 DOI: 10.1007/s11248-023-00341-1] [Reference Citation Analysis]
|
| 3 |
Hosono Y, Uchida S, Shinkai M, Townsend CE, Kelly CN, Naylor MR, Lee HW, Kanamitsu K, Ishii M, Ueki R, Ueda T, Takeuchi K, Sugita M, Akiyama Y, Lokey SR, Morimoto J, Sando S. Amide-to-ester substitution as a stable alternative to N-methylation for increasing membrane permeability in cyclic peptides. Nat Commun 2023;14:1416. [PMID: 36932083 DOI: 10.1038/s41467-023-36978-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Wang F, Sangfuang N, McCoubrey LE, Yadav V, Elbadawi M, Orlu M, Gaisford S, Basit AW. Advancing oral delivery of biologics: Machine learning predicts peptide stability in the gastrointestinal tract. Int J Pharm 2023;634:122643. [PMID: 36709014 DOI: 10.1016/j.ijpharm.2023.122643] [Reference Citation Analysis]
|
| 5 |
Yang Y, Zhou R, Wang Y, Zhang Y, Yu J, Gu Z. Recent Advances in Oral and Transdermal Protein Delivery Systems. Angew Chem Int Ed Engl 2023;62:e202214795. [PMID: 36478123 DOI: 10.1002/anie.202214795] [Reference Citation Analysis]
|
| 6 |
Wang D, Deng B, Cheng L, Li J, Zhang J, Zhang X, Guo X, Yan T, Yue X, An Y, Zhang B, Yang W, Xie J, Wang R. A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis. Acta Pharm Sin B 2023;13:722-38. [PMID: 36873181 DOI: 10.1016/j.apsb.2022.09.001] [Reference Citation Analysis]
|
| 7 |
Bao X, Qian K, Xu M, Chen Y, Wang H, Pan T, Wang Z, Yao P, Lin L. Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery. J Nanobiotechnology 2023;21:16. [PMID: 36647125 DOI: 10.1186/s12951-022-01743-9] [Reference Citation Analysis]
|
| 8 |
Berg S, Uggla T, Antonsson M, Nunes SF, Englund M, Rosengren L, Fahraj M, Wu X, Govender R, Söderberg M, Janzén D, Van Zuydam N, Hugerth A, Larsson A, Abrahmsén-Alami S, Abrahamsson B, Davies N, Bergström CAS. Evaluation in pig of an intestinal administration device for oral peptide delivery. J Control Release 2023;353:792-801. [PMID: 36493948 DOI: 10.1016/j.jconrel.2022.12.011] [Reference Citation Analysis]
|
| 9 |
Berg S, Edlund H, R F Goundry W, A S Bergström C, Davies NM. Considerations in the developability of peptides for oral administration when formulated together with transient permeation enhancers. Int J Pharm 2022;:122238. [PMID: 36174850 DOI: 10.1016/j.ijpharm.2022.122238] [Reference Citation Analysis]
|
| 10 |
Cui J, Wen Z, Zhang W, Wu W. Recent Advances in Oral Peptide or Protein-Based Drug Liposomes. Pharmaceuticals 2022;15:1072. [DOI: 10.3390/ph15091072] [Reference Citation Analysis]
|
| 11 |
Taghizadeh MS, Retzl B, Muratspahić E, Trenk C, Casanova E, Moghadam A, Afsharifar A, Niazi A, Gruber CW. Discovery of the cyclotide caripe 11 as a ligand of the cholecystokinin-2 receptor. Sci Rep 2022;12:9215. [PMID: 35654807 DOI: 10.1038/s41598-022-13142-z] [Reference Citation Analysis]
|
| 12 |
Lamers C. Overcoming the shortcomings of peptide-based therapeutics. Future Drug Discovery 2022;4. [DOI: 10.4155/fdd-2022-0005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
